Latest news
Trump Plans Generic Drug Tariffs From 2028 With Two-Year Delay, Testing U.S. Onshoring Push - CFO Commentary Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:12:25 GMTTrump's Generic Drug Tariff Plan Set for 2028, Testing U.S. Onshoring Push - Tech Earnings Analysis - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:06:48 GMTTrump's 2028 Generic Drug Tariff Plan Tests U.S. Onshoring Push Against India's Supply Grip - Debt Analysis Report - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 09:17:01 GMTTrump to Impose Generic Drug Tariffs Starting 2028, Testing U.S. Onshoring Ambitions - Profit Margin Analysis - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 03:11:10 GMTTrump's Generic Drug Tariff Plan Slated for 2028 Tests U.S. Onshoring Ambitions - Earnings Turnaround - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 00:26:09 GMTTrump Plans Generic Drug Tariffs for 2028 as Two-Year Delay Tests U.S. Onshoring Push - Return On Capital - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 18:01:49 GMTTrump Announces Generic Drug Tariffs Effective 2028, Two-Year Delay Tests U.S. Onshoring Strategy - Earnings Miss Alert - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 16:55:38 GMTTrump's 2028 Generic Drug Tariff Plan Tests U.S. Onshoring Ambitions - Consensus Beat Rate - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 05:15:28 GMT